Poly Medicure Limited (NSE: POLYMED)

Market Cap	261.61B
Revenue (ttm)	15.22B
Net Income (ttm)	2.95B
Shares Out	n/a
EPS (ttm)	30.63
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Sep 19, 2024

Volume	76,601
Open	2,596.60
Previous Close	2,589.05
Day's Range	2,551.35 - 2,644.25
52-Week Range	1,361.00 - 3,357.80
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2024

About Poly Medicure

Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1995
• Employees: 6,300
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: POLYMED

Financial Performance

In 2023, Poly Medicure's revenue was 13.76 billion, an increase of 23.36% compared to the previous year's 11.15 billion. Earnings were 2.58 billion, an increase of 44.05%.